Alliance Pharma plc (LON:APH – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as GBX 61.50 ($0.75) and last traded at GBX 61.20 ($0.75), with a volume of 4399260 shares trading hands. The stock had previously closed at GBX 61.10 ($0.75).
Alliance Pharma Price Performance
The company has a debt-to-equity ratio of 47.46, a current ratio of 2.93 and a quick ratio of 1.42. The business’s 50 day moving average price is GBX 47.38 and its 200 day moving average price is GBX 42.56. The stock has a market capitalization of £330.26 million, a P/E ratio of -1,018.25, a price-to-earnings-growth ratio of 1.04 and a beta of 0.67.
About Alliance Pharma
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.
Read More
- Five stocks we like better than Alliance Pharma
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- What is a Low P/E Ratio and What Does it Tell Investors?
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- What is the MACD Indicator and How to Use it in Your Trading
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
